Related Experiment Video

Updated: Jun 4, 2026

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

Population pharmacokinetics of nalbuphine after surgery in children

F Bressolle1, S Khier, A Rochette

  • 1Pharmacokinetic Laboratory, Faculty of Pharmacy, BP 14491, Montpellier I University, 15 Avenue Ch. Flahault, 34093 Montpellier Cedex 5, France. fbressolle@aol.com

British Journal of Anaesthesia
|February 12, 2011
PubMed

Insights

This study characterized nalbuphine pharmacokinetics in children aged 1-11 years. Clearance decreased and half-life increased with age, aiding pediatric dosing.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Clinical Pharmacy

Background:

  • Nalbuphine is a widely used opioid analgesic for pain management.
  • Limited pharmacokinetic data exist for nalbuphine in pediatric populations.
  • Understanding nalbuphine pharmacokinetics in children is crucial for effective pain control.

Purpose of the Study:

  • To characterize the population pharmacokinetics of nalbuphine in children aged 1 to 11 years.
  • To identify patient factors influencing nalbuphine pharmacokinetic variability.
  • To inform optimal nalbuphine dosing strategies in pediatric patients.

Main Methods:

  • A population pharmacokinetic analysis was performed on data from 22 pediatric patients receiving nalbuphine post-surgery.
  • A two-compartment structural model was employed using non-linear mixed-effects modeling.
  • Blood samples were collected from each patient to analyze nalbuphine concentrations.

Main Results:

  • Population pharmacokinetic parameters were estimated and standardized to a 70 kg body weight using an allometric model.
  • Total clearance (L/h/kg) significantly decreased with increasing age in pediatric patients.
  • Elimination half-life significantly increased with age, indicating age-related pharmacokinetic changes.

Conclusions:

  • An allometric power model effectively described nalbuphine pharmacokinetics in the studied pediatric population.
  • The developed model may assist in adjusting nalbuphine dosage for children.
  • Further research can refine dosing based on age-related pharmacokinetic profiles.
Abstract

More Related Videos

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery09:47

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery

Published on: June 2, 2022

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...